Overview

The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the combination of galantamine with nimodipine in patients with mixed dementia on cognition and quality of life.
Phase:
Phase 4
Details
Lead Sponsor:
Janssen-Cilag Farmaceutica Ltda.
Treatments:
Galantamine
Nimodipine